Newsroom
Sorted by: Latest
-
Deutsche Bank AG UK Regulatory Announcement: Value per Security
LONDON--(BUSINESS WIRE)-- DB ETC PLC Dated: 06 January 2026 COMPANY ANNOUNCEMENT Immediate Release 06 January 2026 DB ETC plc (the Issuer) (incorporated and registered in Jersey under the Companies (Jersey) Law 1991 (as amended) with registered number 103781) Re: Value per Security of ETC Securities Announcement The Issuer is providing the Value per Security for the ETC Securities for the following Series as set out in the table below for 05 January 2026 Series ISIN Currency Value per Security...
-
Lysoway Therapeutics Announces Phase I Readiness of Brain-Penetrant TRPML1 Agonist LW-1017 and Nomination of a TMEM175 Development Candidate
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Lysoway Therapeutics, Inc., a biotechnology company advancing structure-guided small-molecule modulators of lysosomal ion channels to treat age-related neurodegeneration, today announced that its lead TRPML1 agonist, LW-1017, is Phase I ready. A first-in-human (FIH) study is planned in Australia, with first patient first dose (FPFD) targeted for May 2026. The Company also announced the formal nomination of a development candidate for its TMEM175 agonist progra...
-
Balyasny Asset Management LP UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...
-
PRMB Investor Alert: Hagens Berman Scrutinizing Alleged Undisclosed Technology Failures and Supply Chain Risks in Pending Primo Brands (PRMB) Lawsuit
SAN FRANCISCO--(BUSINESS WIRE)--National shareholder rights law firm Hagens Berman is alerting investors in Primo Brands Corporation (NYSE: PRMB) that the deadline to move the Court for appointment as lead plaintiff in the pending securities class action lawsuit is January 12, 2026. The firm urges investors who suffered substantial losses to contact our firm now. The lawsuit seeks to recover investor losses sustained after the disclosure of an allegedly concealed severe, operational crisis foll...
-
StubHub (STUB) Slapped with Securities Lawsuit Over IPO Disclosures -- Hagens Berman
SAN FRANCISCO--(BUSINESS WIRE)--National shareholder rights law firm Hagens Berman is issuing a reminder to investors in StubHub Holdings, Inc. (NYSE: STUB) ahead of the January 23, 2026, deadline of their opportunity to seek appointment as lead plaintiff in the pending securities class action lawsuit. The litigation centers on allegations that StubHub’s highly anticipated September 2025 Initial Public Offering (IPO) was launched using Offering Documents that contained material misstatements an...
-
Coupang (CPNG) Hit With Securities Class Action Amid Massive Data Breach, Questions About Timely Disclosure, Executive Departure – Hagens Berman
SAN FRANCISCO--(BUSINESS WIRE)--A securities class action lawsuit styled Barry v. Coupang, Inc., et al., No. 5:25-cv-10795 (N.D. Cal.) has been filed, seeking to represent investors in Coupang, Inc. (NYSE: CPNG) who purchased or otherwise acquired Coupang securities between August 6, 2025 and December 16, 2025. The lawsuit comes in the wake of reports of Coupang’s massive data breach and the company’s alleged delay in disclosing it. The unfolding news has driven the price of Coupang shares sign...
-
Andersen Global Broadens Tax Capabilities in Africa with Addition of Luca Pacioli
SAN FRANCISCO--(BUSINESS WIRE)--Andersen Global enhances its footprint in North Africa through a Collaboration Agreement with Luca Pacioli....
-
SullivanCotter Opens Participation for 2026 Health Care Compensation Surveys
CHICAGO--(BUSINESS WIRE)--SullivanCotter Opens Participation for 2026 Health Care Compensation Surveys...
-
1910 Publishes PEGASUS™, a Multimodal AI Model that Engineers Novel Drug-Like Macrocyclic Peptides
BOSTON--(BUSINESS WIRE)--1910, the only AI-native biotech pioneering small and large molecule therapeutics discovery, today announced the publication of PEGASUS™, a multimodal AI model that achieves state-of-the-art accuracy in predicting and designing cell-permeable macrocyclic peptides. As featured in the Journal of Medicinal Chemistry, PEGASUS™ generated the first reported macrocyclic peptides containing more than two polar or charged fragments that demonstrate in vitro cell permeability, ad...
-
NeoCurrency Celebrates 10 Years of Innovation in Global Rewards, Incentives & Payments
LOS ANGELES--(BUSINESS WIRE)--NeoCurrency, a leading global provider of digital rewards, incentives and payout solutions, is celebrating its 10th anniversary in 2026. The company has achieved a decade of helping brands, promotional agencies, loyalty programs, researchers and employers reward people across the world with unmatched choice, reach and simplicity. Founded in 2016 by industry veterans Geoff Miller (CEO) and Josh Storm (CCO), NeoCurrency began as a small startup with a big mission: to...